Seeing Is Believing
Currently out of the existing stock ratings of Lucas Lee, 2 are a HOLD (50%), 2 are a BUY (50%).
Analyst Lucas Lee, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 100% that have a potential upside of 14.86% achieved within 52 days.
Lucas Lee’s has documented 6 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ZTS, Zoetis at 16-Jul-2021.
Analyst best performing recommendations are on ZTS (ZOETIS).
The best stock recommendation documented was for ZTS (ZOETIS) at 3/8/2021. The price target of $166 was fulfilled within 43 days with a profit of $23.12 (16.18%) receiving and performance score of 3.76.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$130
$1.82 (1.42%)
$160
26 days ago
(18-Nov-2025)
10/22 (45.45%)
$11.86 (10.04%)
179
Buy
$160
$31.82 (24.82%)
$225
1 months 2 days ago
(12-Nov-2025)
0/3 (0%)
$38.75 (31.96%)
Buy
$190
$61.82 (48.23%)
$190
3 months 5 days ago
(09-Sep-2025)
4/5 (80%)
$40.21 (26.84%)
180
Buy
$215
$86.82 (67.73%)
$210
4 months 3 days ago
(11-Aug-2025)
2/12 (16.67%)
$65.98 (44.28%)
153
Buy
$244
$115.82 (90.36%)
$242
10 months ago
(14-Feb-2025)
6/12 (50%)
$87.54 (55.95%)
147
What Year was the first public recommendation made by Lucas Lee?